Clueo Clinical is proud to announce that we have been selected as one of only 20 Queensland companies by the Queensland Government to participate in Australia’s Business Mission to India for BioAsia 2026.
Our Founder & CEO, Dr Thu (Sue) Nguyen, is attending BioAsia in Hyderabad and business meetings in Bengaluru from 16–20 February 2026, representing Queensland’s innovation and clinical research capability.
We sincerely thank Trade and Investment Queensland and Austrade for supporting Australian organisations to engage with India’s rapidly growing life-sciences ecosystem.
BioAsia is one of Asia’s premier biotechnology and life-sciences events, bringing together global leaders across pharmaceuticals, biotech, clinical research, and healthcare innovation.
At Clueo Clinical, we design globally compliant clinical workforce systems that enable organisations to scale Phase I–III trials with speed, regulatory confidence, and inspection-ready execution. This visit presents an important opportunity to explore how Clueo Clinical can support India’s expansion of clinical trials into Australia through workforce and operational excellence.
If you are attending BioAsia or based in Hyderabad or Bengaluru during this time, we welcome the opportunity to connect.
📩 Contact us at info@clueoclinical.com to arrange a meeting. 🎯 Download our Capability Statement below.
Send download link to: